文献速递心境障碍

氟脱氧葡萄糖-正电子发射断层扫描作为预测和优化胼胝体下扣带回区深部脑刺激反应的术前生物标志物

Fluorodeoxyglucose-Positron Emission Tomography as a Preoperative Biomarker for Predicting and Optimizing Response to Subcallosal Cingulate Area Deep Brain Stimulation.
PubMed 文献 · Biol Psychiatry · 2025-05-20

本研究评估基于术前FDG-PET三个脑区葡萄糖代谢值的支持向量机模型对难治性抑郁症患者SCC-DBS治疗反应的样本外预测性能。模型在35例未见验证集中分类准确率77.1%,置换检验显著(ppermute=.008),并发现颞极代谢较低者钩束参与与临床结局耦合更强。

要点

  • 术前FDG-PET的SVM模型在样本外验证中分类SCC-DBS治疗反应准确率77.1%。
  • 该模型性能经置换检验显著(ppermute=.008),优于另一种临床信息SVM。
  • 颞极代谢较低者钩束参与与临床结局的耦合更强(p=.027)。

核心结论

  • FDG-PET模型可预测SCC-DBS治疗难治性抑郁症的结局,有助于优化患者选择和个体化DBS治疗。

研究设计与样本

  • 基线FDG-PET数据预处理后输入支持向量机分类器,模型使用额极、前扣带回和颞极三个区域输入。
  • 模型在熟悉的21例难治性抑郁症队列中训练和调参,在未见验证集(n=35)中测试。
  • 在合并队列中探索葡萄糖代谢对白质纤维束刺激与临床结局关系的影响。

主要发现

  • 模型分类样本外反应状态的准确率为77.1%(精确率80.0%,召回率87.0%,F1分数0.83)。
  • 该性能在置换检验中显著(ppermute=.008),并超过另一种临床信息SVM。
  • 颞极代谢较低的患者中,钩束参与(用电极定位和激活建模近似)与临床结局的耦合更强(p=.027)。

关键数值与推荐

  • 模型样本外分类准确率77.1%,精确率80.0%,召回率87.0%,F1分数0.83。
  • 置换检验ppermute=.008。
  • 颞极代谢与钩束参与-临床结局耦合关系的p=.027。

临床怎么用

  • 术前FDG-PET模型可用于预测SCC-DBS治疗反应,辅助筛选适合患者。
  • 颞极代谢信息可能帮助进一步个体化DBS治疗参数或靶点选择。

局限性

  • 验证集样本量有限(n=35),模型仅在单一队列中训练和测试。
  • 钩束参与为近似建模,非直接测量。
  • 结论需更大样本和外部验证确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deep brain stimulation targeting the subcallosal cingulate area (SCC-DBS) has emerged as a promising therapy for treatment-resistant depression (TRD). However, only one-half to two-thirds of patients experience meaningful clinical response, highlighting the need for biomarkers that could help to optimize SCC-DBS outcomes. Our group previously showed that a support vector machine (SVM) incorporating preoperative fluorodeoxyglucose-positron emission tomography (FDG-PET) glucose metabolism values from the frontal pole, anterior cingulate cortex, and temporal pole could retrospectively classify treatment response in 21 patients with TRD with 81.0% accuracy. Here, we assessed the out-of-sample performance and wider applicability of this putative biomarker. METHODS: Baseline FDG-PET data were preprocessed and fed into an SVM classifier. This model, which utilized the 3 regional inputs mentioned above, was trained and tuned using the familiar 21-patient cohort and tested on an unseen TRD validation set (n = 35). Within the combined cohort, we also explored glucose metabolism's potential influence on previously demonstrated relationships between white matter tract stimulation and clinical outcome. RESULTS: Our model classified out-of-sample response status with 77.1% accuracy (80.0% precision, 87.0% recall, 0.83 F1 score). This performance proved statistically significant in permutation testing (ppermute = .008) and exceeded that of an alternative, clinically informed SVM. In addition, we found that patients with lower temporal pole metabolism showed stronger coupling between uncinate fasciculus engagement (approximated using electrode localization and activation modeling) and clinical outcome (p = .027). CONCLUSIONS: These results corroborate the validity of FDG-PET models as tools for predicting SCC-DBS outcomes and underscore their value in refining patient selection and further personalizing DBS treatment.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Elias GJB, Iskin SA, Beyn ME, et al. Fluorodeoxyglucose-Positron Emission Tomography as a Preoperative Biomarker for Predicting and Optimizing Response to Subcallosal Cingulate Area Deep Brain Stimulation. Biol Psychiatry. 2025. PMID: 40403825. doi:10.1016/j.biopsych.2025.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。